Global cord blood corporation announces failure to file interim financials

George town, cayman islands and hong kong , april 13, 2023 /prnewswire/ -- global cord blood corporation (nyse: co) (the "company"), a provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services in china, announced that it received a notice (the "notice") on april 3, 2023 from the new york stock exchange ("nyse") with respect to its failure to timely file on form 6-k its semi-annual financials for the six-month period ended september 30, 2022 (the "interim financials") as required by nyse listing standard 203.03.
CO Ratings Summary
CO Quant Ranking